Maryland Goes a Step Further to Rein in Drug Price Spikes image

Regulatory Affairs Professionals Society (RAPS), February 27, 2017
Zachary Brennan, citing Rachel E. Sachs (Academic Fellow Alumna)

Links

Read the Full Round-Up

[...] The bill has drawn criticism from industry groups and others who say such independent audits would be overly burdensome for industry and that the $2500 threshold might include too many drugs as other states have included a $10,000 threshold, though other experts think the legislation is a step in the right direction. [...]

health care finance health law policy pharmaceuticals public health rachel sachs regulation